Bio adhesive Market is Deliberately Recording a Promising CAGR of 6.9% During Forecast to 2027


Market Overview:
Increasing prevalence of diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for research and development, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the Bio adhesive Industry Growth during the forecast period. However, high cost of the treatment may slow the Bio Adhesive Market growth during the period 2017-2027.
Bio adhesives are polymers that have an abilities to adhere to a biological tissue for an extended period of time. There are two major types of bio adhesive, plant based and animal based bio adhesive. Bio adhesives have been investigated as potential drug delivery systems for oral administration. There are various medicine where bio adhesive are used such as nasal spray ear drops, eye drops, ointment, hydrogel, nano sphere suspension, insufflation, and microsphere tablet. Moreover, over the last decade Bio adhesives Market Size is considering one of the best drugs for the treatment of oral administration
The increase in patient population of dental and ophthalmic diseases is increasing the demand for bio adhesive in global market. According to report published by the World Health Organization (WHO), in 2017, number of population suffering with vision impairment could triple due to ageing population growth, and it is projected that by 2050 around 115 million people will get blind and by 2020. Report suggest that around 19 million children below age 15 years are vision impaired, including 12 million children who have a vision impairment due to refractive error and 1.4 million have irreversible blindness. 
Key Players:
·         Bioadhesive Alliance Inc
·         Camurus
·         Henkel Corporation
·         Ashland Inc
·         3M Company
·         Adhesives Research
·         Yparex B.V.
·         EcoSynthetix Inc
·         Adhbio
Global Bio Adhesive Market   - Competitive Analysis
April, 2016- Camurus Company had signed agreement with R-PHARM U.S. (Princeton, NJ) and had granted the exclusive license and distribution rights for episil oral liquid in the U.S. R-PHARM US was founded in 2014 with the goal of acquiring and commercializing products that help patients suffering from cancer and immunology conditions. As per company reports, R-PHARM US is a subsidiary of R-PHARM JSC, global pharmaceutical business with 2015 sales of ~$1.5B, primarily in Russia and Eastern Europe. R-PHARM’s portfolio includes IXEMPRA, a chemotherapy agent approved for metastatic breast cancer, and a pipeline that includes molecules being developed for immunology and oncology indications.  The most advanced pipeline asset is olokizumab, a Phase 3-ready IL-6 being developed for rheumatoid arthritis and other immunologic conditions. And episil oral liquid, is a unique and effective treatment for the pain of oral mucositis, a treatment-limiting side effect of cancer therapies, as well as other oral lesions. As per company reports, Camurus's technology FluidCrystal, episil is administered as a lipid-based liquid that spreads on the intra-oral mucosal surfaces and transforms to a strongly bioadhesive film that mechanically protects the sensitized and sore epithelium of the oral cavity.
Europe dominate the global bio adhesive market owing to the presence of manufactures and increasing government support for research & development. Moreover increasing demand of bio adhesive globally leads the manufacturer increase the export of these products and capture highest market share in global market.

Comments

Post a Comment

Popular posts from this blog

Gene Therapy Market Mobilizing Viral Vector Manufacturing Market

Market Overview: The global viral vector manufacturing market is expected to exhibit a strong 22.65% CAGR over the forecast period from 2018 to 2023 , according to the latest research report from Market Research Future (MRFR). The report forecasts a valuation of USD 319 million for the market by the end of the 2018-2023 forecast period. In current time, gene therapy is one of the preferred treatment options for most chronic diseases, that involves the insertion of a functional copy of a gene into a defective cell. viral vectors and the absence of the appropriate tools are likely to be the key restraints acting against the global Viral Vector Manufacturing Market Size over the forecast period. Many companies in the global viral vector manufacturing market are taking steps to counter the difficulties in producing viral vectors and this area is likely to remain a hive of activity in the coming years. This has also resulted in strong growth prospects for companies that can develop e...
Read more

Negative Pressure Wound Therapy Market is Increasing at a Healthy CAGR of 6.7% During Forecast to 2023

    MRFR Processed new research on “Negative Pressure Wound Therapy Market-Global Forecast to   Market Analysis:    The worldwide negative pressure wound therapy market is predicted to grow at a 6.7% CAGR during the forecast period (2018-2023), according to the latest Market Research Future (MRFR) report. Negative pressure wound therapy or NPWT, which is also called vacuum-assisted wound closure, includes the use of sub-atmospheric pressure for healing chronic and acute wounds. These devices come in assorted sizes and shapes to match the patient’s body contour and also the wound size to be treated. NPWT devices have a dressing set, drainage tubing, and vacuum pump that along with promoting wound healing also helps in reducing recurrent usage of dressings, offer an effective choice for managing closed surgical incision lines as well as augment the well-being of the patient.    Also Read: https://www.medgadget.com/2020/02/negative-pressur...
Read more

North Americas Uplifting 3D Printed Medical Implants Market

Market Overview: Expanding innovative advances in 3D printed implants, for example, improvement of CT-Bone, bone indistinguishable redid embed for use in mandible and zygoma increase procedure should help business development. Its controlled porosity empowers it to fit life structures of the patient, in this manner, dominatingly driving industry development. Also, increment in medicinal services consumption, ascend in R&D venture, flood in number of medical procedures and expanding extent of 3D innovation in biomedical application will spike income size during the figure time frame. In any case, factors, for example, significant expense of printers, longer creation courses of events, absence of talented representatives and absence of in-house added substance fabricating assets is relied upon to obstruct 3D printed implants market development over the coming years. The market for 3D Printed Medical Implants Market   is likely to register a CAGR of 18.1% during the foreca...
Read more